Current Assets Changement Date
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Immunic USD 65.23M 21.32M 2023-09
Insmed USD 929.06M 2.49M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Kyowa Hakko Kirin JPY 581.36B 7.3B 2023-09
Moderna USD 10.32B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xoma USD 34.5M 3.92M 2023-09



Ultragenyx Pharmaceutical Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.